SAN DIEGO, June 7, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today shared key customer-focused announcements and presentations ...
When gene sequencer giant Illumina (NASDAQ: ILMN) rolled out plans last month to replace the high-performance models of its instruments with a whole new lineup, the market cheered, and the stock rose ...
Article tools E-mail this article Print-friendly version Discuss this articleStocks mentioned in this articleIllumina Inc (ILMN) Stock Quote, Chart, News, Add to WatchlistRelated newsPremarket Movers: ...
Personal genomics company Helix and Illumina are partnering to support consumer genomics startups. Helix is teaming up with Illumina Accelerator to provide resources and support for innovative ...
Illumina has a profitable business in a large and growing market. Q1 results were strong and since then the stock is up 15%. Q2 should provide more of the same and a good read on key growth drivers.
When gene sequencer giant Illumina (NASDAQ: ILMN) rolled out plans last month to replace the high-performance models of its instruments with a whole new lineup, the market cheered, and the stock rose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results